Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02125357
Title Sequencing Abiraterone and Enzalutamide in mCRPC
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors British Columbia Cancer Agency
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Abiraterone

Age Groups: adult
Covered Countries CAN


No variant requirements are available.